|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.800 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
5546 |
| Gene Symbol: |
PRCC |
PRCC
|
0.430 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
7030 |
| Gene Symbol: |
TFE3 |
TFE3
|
0.360 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
84925 |
| Gene Symbol: |
SLC49A4 |
SLC49A4
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
11236 |
| Gene Symbol: |
RNF139 |
RNF139
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
6927 |
| Gene Symbol: |
HNF1A |
HNF1A
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
6928 |
| Gene Symbol: |
HNF1B |
HNF1B
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
4968 |
| Gene Symbol: |
OGG1 |
OGG1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
2705 |
| Gene Symbol: |
GJB1 |
GJB1
|
0.300 |
Biomarker
|
disease |
CTD_human |
5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
|
18264126 |
2008 |
|
| Entrez Id: |
4286 |
| Gene Symbol: |
MITF |
MITF
|
0.500 |
SusceptibilityMutation
|
disease |
ORPHANET |
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
22012259 |
2011 |
|
| Entrez Id: |
4286 |
| Gene Symbol: |
MITF |
MITF
|
0.500 |
Biomarker
|
disease |
CTD_human |
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
22012259 |
2011 |
|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.
|
15557554 |
2004 |
|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Activating mutations for the met tyrosine kinase receptor in human cancer.
|
9326629 |
1997 |
|
| Entrez Id: |
9370 |
| Gene Symbol: |
ADIPOQ |
ADIPOQ
|
0.300 |
Biomarker
|
disease |
CTD_human |
Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
|
29723618 |
2018 |
|
| Entrez Id: |
238 |
| Gene Symbol: |
ALK |
ALK
|
0.300 |
Biomarker
|
disease |
CTD_human |
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
|
22743654 |
2012 |
|
| Entrez Id: |
8314 |
| Gene Symbol: |
BAP1 |
BAP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
BAP1 loss defines a new class of renal cell carcinoma.
|
22683710 |
2012 |
|
| Entrez Id: |
7428 |
| Gene Symbol: |
VHL |
VHL
|
0.370 |
Biomarker
|
disease |
CTD_human |
Bilateral renal-cell carcinoma associated with an acquired VHL mutation and long-term trichloroethylene exposure.
|
19473641 |
2009 |
|
| Entrez Id: |
10950 |
| Gene Symbol: |
BTG3 |
BTG3
|
0.300 |
Biomarker
|
disease |
CTD_human |
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
|
19221000 |
2009 |
|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.800 |
Biomarker
|
disease |
CLINGEN |
c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations.
|
18055465 |
2008 |
|
| Entrez Id: |
1381 |
| Gene Symbol: |
CRABP1 |
CRABP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma.
|
16254461 |
2005 |
|
| Entrez Id: |
210 |
| Gene Symbol: |
ALAD |
ALAD
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
|
21799727 |
2011 |
|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.800 |
SomaticCausalMutation
|
disease |
ORPHANET |
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
|
26536169 |
2016 |
|
| Entrez Id: |
3855 |
| Gene Symbol: |
KRT7 |
KRT7
|
0.320 |
Biomarker
|
disease |
CTD_human |
Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
|
16927643 |
2006 |
|
| Entrez Id: |
5816 |
| Gene Symbol: |
PVALB |
PVALB
|
0.300 |
Biomarker
|
disease |
CTD_human |
Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
|
16927643 |
2006 |
|
| Entrez Id: |
3855 |
| Gene Symbol: |
KRT7 |
KRT7
|
0.320 |
Biomarker
|
disease |
CTD_human |
Differential protein profiling in renal-cell carcinoma.
|
15108329 |
2004 |